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Background: Systematic reviews have shown that, although well prepared, the Consensus Guidelines have failed to
change clinical practice. In the healthcare district of Castelnovo né Monti (Reggio Emilia, Italy), it became necessary for the
GPs and Clinical Pathologists to work together to jointly define laboratory profiles.
Methods: Observational study with two cycles of retrospective audit on test request forms, in a primary care setting.
Objectives of the study were to develop pathology-specific laboratory profiles and to increase the number of provisional
diagnoses on laboratory test request forms. A Multiprofessional Multidisciplinary Inter-hospital Work Team developed
pathology-specific laboratory profiles for more effective test requesting. After 8 training sessions that used a combined
strategy with multifaceted interventions, the 23 General Practitioners (GPs) in the trial district (Castelnovo nè Monti) tested
the profiles; the 21 GPs in the Puianello district were the control group; all GPs in both districts participated in the trial. All
laboratory tests for both healthcare districts are performed at the Laboratory located in the trial district. A baseline and a
1-year audit were performed in both districts on the GPs’ request forms.
Results: Seven pathology-specific laboratory profiles for outpatients were developed. In the year after the first audit cycle:
1) the number of tests requested in the trial district was distinctly lower than that in the previous year, with a decrease of
about 5% (p< 0.001); 2) the provisional diagnosis on the request forms was 52.8% in the trial district and 42% in the
control district (P< 0.001); 3) the decrease of the number of tests on each request form was much more marked in the
trial district (8.73 vs. 10.77; p< 0.001).
Conclusions: The first audit cycle showed a significant decrease in the number of tests ordered only in the trial district.
The combined strategy used in this study improved the prescriptive compliance of most of the GPs involved. The
presence of the clinical pathologist is seen as an added value.Background
In 1995, McDonald and Smith stated that the clinical
pathologist “must add value and medical relevance to
the healthcare system to earn and maintain” an import-
ant role. [1] As the last 20 years have witnessed an enor-
mous increase in laboratory medicine know-how and
technology and the use of practical guidelines and* Correspondence: Danilo.Orlandini@asmn.re.it
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reproduction in any medium, provided the orlaboratory profiles (a battery of tests) has increased sig-
nificantly, clinical pathologists now more than ever have
the opportunity to play an influential leadership role. [2]
Indeed, positive experiences have highlighted the ele-
ments necessary to preparing a clinical practice guide-
line: there must be a multidisciplinary team that
formulates clear and reasonable recommendations [3]
after conducting a systematic review of the literature, an
assessment of the quantity and quality (consistency, clin-
ical impact, and organizational relationships) of the
evidence.
Compliance with the guidelines does not automatically
translate into appropriate patient care, however. Thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tions and what doctors actually do may indicate that
guidelines are incomplete or that new evidence has made
them obsolete [4].
There is a limited evidence base to support decisions
about which guideline dissemination and implementa-
tion strategies are likely to be effective and efficient
under different circumstances [5].
While not considered useful for solving particularly
complex clinical problems, algorithms or, in our case,
pathology-specific laboratory profiles are simpler than
clinical guidelines as tools for guiding individual actions
or decisions. Thanks to their simplicity they can be
incorporated in computerized programs and produced
in the form of flowcharts.
In Italy, GPs are directly responsible for prescribing
outpatient laboratory tests. Approximately 30% of the
outpatient laboratory tests are ordered without a definite
working diagnosis; in these cases they are ordered, for
example, “just to check,””to reassure my patients,” “be-
cause lab tests should be done at least once a year,” “for
prevention,” and so on [6-8].
The healthcare services in the province of Reggio Emi-
lia have proposed laboratory profiles that can be used in
different ways [9].
The Clinical Pathology and Transfusion Laboratory of
Castelnovo nè Monti (Reggio Emilia) performs all la-
boratory tests for the healthcare districts of Castelnovo
nè Monti and Puianello.
The district of Castelnovo nè Monti has 33,000 inhabi-
tants, 23 GPs, and a hospital with basic functions. The
district of Puianello has about 23,000 inhabitants and
21 GPs; residents generally refer to the nearby main
hospital of the province.
In 2007, a rapid increase in the number of laboratory
tests ordered in a healthcare district in the province of
Reggio Emilia (Castelnovo nè Monti) was observed, along
with extreme prescriptive variability that was not necessar-
ily strictly related to the variability of clinical situations. It
was thus decided that the GPs and the Clinical Pathologists
in this district would work together to jointly define labora-
tory profiles in order to reduce the number of unnecessary
tests and ultimately, to allocate resources more efficiently.
The district of Castelnovo nè Monti was to be the pro-
ject’s trial setting, while that of Puianello would be the
control setting.
The short-term objective of the project was to develop
pathology-specific laboratory profiles, a new method for
requesting laboratory tests that was based on strong sci-
entific evidence of efficacy without reducing the physi-
cians’ power of discretion.
The main objectives of the project were to develop
pathology-specific laboratory profiles and to increase the
number of provisional diagnoses on laboratory test requestforms, and were evaluated by means of a retrospective
audit in both settings on the number of tests ordered over
the same period of time, the presence of the provisional
diagnosis on laboratory test request forms, and the average
number of tests ordered on each GP request form.
Methods
Setting
In order to test the effectiveness of the pathology-
specific laboratory profiles in reducing the number of in-
appropriate laboratory test requesting, two healthcare
districts that refer to the same laboratory were chosen as
the trial and the control setting.
Study design
Observational study with two cycles of retrospective
audit on test request forms, in a primary care setting.
Intervention
In 2007 the Multiprofessional Multidisciplinary Inter-
hospital Work Team was formed to evaluate the clinical
laboratory test requesting habits of GPs in the Castel-
novo nè Monti district. This team included GPs, clinical
pathologists, hospital specialists, expert laboratory tech-
nicians, and medical statisticians.
The GPs involved prepared certain provisional diagno-
ses and one of the team’s members (RB) conducted a
search on Medline (Pubmed), Embase, and The Cochrane
Library, through the portal of the Healthcare Library -
Clinical Governance Documentation Centre of the
Healthcare Trusts of the Province of Reggio Emilia, using
different appropriate combinations of the search terms.
Based on the results of this search and the evidence
provided in the literature, the Multiprofessional Multi-
disciplinary Inter-hospital Work Team defined recom-
mendations for the most effective use of laboratory
tests in the clinical conditions selected. Pathology-
specific laboratory profiles for these clinical conditions
were developed and were presented and discussed with
the GPs and hospital specialists of the Castelnovo nè
Monti healthcare district (trial setting).
All laboratory tests for both healthcare districts are
performed at the Laboratory located in the trial district.
All GPs in both districts participated in the trial.
Training sessions (8 in 2007) were organized in
order to provide these GPs with the opportunity to
understand the profiles and the scientific rationale
underlying them, and to discuss their presumed useful-
ness. These training sessions were based on formal
local consensus and on a combined strategy with
multifaceted interventions like audit and feedback,
reminders, marketing, and so on. [10].
As the Puianello district represented the control set-
ting of this project, the GPs there received no training.
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Baseline data on the total yearly number of test request
forms and the total number of ordered tests were col-
lected in both districts.
Thirty days were randomly selected over the course of
one year on which the total number of test request forms
and the total number of ordered tests were recorded (each
request form may contain up to 8 tests, because the Emilia
Romagna Region Healthcare system allows up to 8 tests
on each request form); the request forms were then
checked to see if the provisional diagnosis was present.
A year after introducing the new profiles in the Castel-
novo nè Monti district, data on the number of test request
forms and the total number of tests ordered were again col-
lected in both the districts by means of the same method.
The test request forms were evaluated by the administrative
staff of the Clinical Pathology and Transfusion Laboratory
using the grid developed by Multiprofessional Multidiscip-
linary Inter-hospital Work Team during the definition of the
profiles. Data were immediately rendered anonymous andTable 1 Descriptions of the seven pathology-specific laborato
Table 1: Profile
1. Normal Adult Profile An analysis of the literature shows that ther
provisional diagnosis (or if a generic clinical
however vague and indistinct, such as asthe
Society of Clinical Pathology concluded tha
when applied to different groups of patient
[7,13] Patients often see undergoing laborat
It is the combination of guidelines, policy m
is associated with significant reduction of th
This profile consists of 8 parameters which e
Haemopoiesis: the haemachrome has 30 pa
Renal function: creatinine and complete urin
Overall metabolism: the total cholesterol an
As we could not find any useful indications
repeated in a single year in a symptom-free
at once a year.
2. Patient with Myeloma
[16,17]
Haemochrome, creatinine, protein electroph
once a year or if there is a change in the cli
Optional (but not useful in follow up):
Serum and urine immunofixation, Immunog
3. MGUS [14,18] After initial classification
Electrophoresis once per year.
Reassess the patient to see if the clinical situ
4. Active chronic hepatitis Normal Adult profile and Got as initial classi
Gpt - Got - haemachrome in monitoring;
The serum tests for HBV and HCV are only p
5. Thyroid TSH by screening (with the exception of pre
Only if pathological TSH starts “Reflex Test”
Antiperoxidase Antibodies. [21]
6. Hypertension Normal Adult Profile (but optional)-na-k-cl-c
TSH: as initial classification in those diagnos
if there is a change in the clinical condition
For monitoring we strongly recommend tha
are ordered (for example: creatinine, sodium
7. Estro-progestogenic
treatment
Normal Adult Profile is optional and not rec
Evaluation of V Leiden Factor and of mutati
only in patients with family history or patho
initiating drug therapy. [12]thus no researcher was able to identify any patient in any
way whatsoever. Obtaining informed consent and the ap-
proval of the ethics committee were therefore not necessary.
The study design was approved by the Institutional
Review Board and by the Primary care Board of the
Reggio Emilia Health Authority.
Data analysis
The weekly average number of the prescriptions (test re-
quest forms and ordered tests) and the percentage of
how often the provisional diagnosis was indicated on the
request forms were calculated. The statistical signifi-
cance was calculated with the χ2 test for 2-dimensional
arrays data.
The indicators used were:
1) Numerator: number of tests ordered during the































logicaDenominator: number of tests ordered during the
baseline auditofiles
rofile description
rationale for ordering laboratory tests if there is no precise
ion is at least present) generated by the presence of symptoms,
ver, and so on. In clinical trials in 1999 and 2005, the Japan
was a great deal of diversity in the efficacy of the same profile
that it was futile to order tests repeatedly in a single year.
sts as unavoidable, even when no clinical signs are present [14].
ations to laboratory access, and changes in payment policies that
of laboratories.[15]
e the main organs or systems:
ers useful for identifying numerous pathologies;
(itself containing 20 analytical parameters);
actions (HDL and LDL), gpt, glycaemia.
literature as to how often the profile should be
ct, we set the maximum frequency for our healthcare setting





ed for diagnostic purposes and are generally not repeated. [19,20]
women).
include FT4/FT3 and, only in the first test,
acid;
h hypertension the first time. Normally repeated only
atment.
individual tests considered to be necessary
potassium). [11]
nded.
the gene coded for Prothrombin (G20210A) is recommended
l history of venous thrombosis. Conducted only once before
Figure 1 Number of tests ordered in Castelnovo né Monti trial district (dark gray bar) and in Puianello district (light gray bar) during
the course of the year, from 2005 to 2008. The baseline audit was conducted in the year 2007 and the 2nd cycle of audits was completed in
2008.
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indication of provisional diagnosis during the audit
period
Denominator: total number of request forms during
the audit periodFigure 2 Average number of laboratory tests ordered on a single reque
gray line for the Castelnovo né Monti trial district; Light gray line for th3) Numerator: average number of tests ordered on
each GP request form during the second audit
cycle
Denominator: average number of tests ordered on
each GP request form during the baseline audit.st form during the course of the year, from 2005 to 2008. Dark
e Puianello control district.
Table 2 Total number of tests ordered, Weekly number of
test ordered, Average of laboratory tests ordered on
each GP request form, before and after the introduction
of the profiles. (* p<0,001)
Table 2 Baseline Audit 2nd Audit
Total N° of Tests: Castelnovo nè Monti 388790 370472*
Total N° of Tests: Puianello 199547 201662*
Weekly N° of Tests: Castelnovo nè Monti 880 789*
Weekly N° of Tests: Puianello 642 648
Average of tests ordered on each GP
request form: Castelnovo nè Monti
10,77 8,73*
Average of tests ordered on each GP
request form: Puianello
10,90 9,20
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criteria) to write the report.
Results
Laboratory profiles
The following seven pathology-specific laboratory profiles
for the first visit, for subsequent visits, and for day surgery
patients were developed (see Table 1 for descriptions):
1. Normal Adult Profile
2. Myeloma
3. MGUS (Monoclonal Gammopathy of Undetermined
Significance)
4. Active chronic hepatitis
5. Thyroid profileFigure 3 Provisional diagnosis present on order forms. Dark gray bars for
Puianello control district. The baseline audit was conducted in the year 2007,6. Hypertension profile
7. Estro-progestogenic treatment profileClinical audit
The Clinical Pathology and Transfusion Laboratory activity
data show that there was an increase in the number of tests
ordered in the Castelnovo né Monti district (trial setting)
between 2005 and 2007; a year after the introduction of
the profiles (2008), the number of tests ordered in the same
district was distinctly lower (2007:388790; 2008:370472), a
decrease of about 5%. In the Puianello district (control set-
ting), the increase was constant over the years examined,
with an increase in the number of laboratory tests between
2007 and 2008 (199547 vs. 201662) of more than 1%.
(Figure 1). These variations are statistically significant
(p< 0.001).
In 2007 (baseline audit), there was an average of 880
laboratory test orders per week in the trial setting (Cas-
telnovo né Monti) and an average of 642 test orders per
week in the control setting (Puianello). At the end of
2008, after the training course, there was an average of
789 test orders per week in the trial setting (Castelnovo
né Monti), compared to 648 test orders per week in the
control setting (Puianello).
As GPs can order more than one test on a single re-
quest form, we also calculated the average number of la-
boratory tests ordered on each GP request form in the
years between 2005 and 2008. A similar trend was seen
in both districts, with an increasing ratio through 2007
and a reduction in 2008. This decrease was much morethe Castelnovo né Monti trial district; Light gray bars for the
and the 2nd cycle of audit was completed in 2008.
Table 3 Provisional diagnosis on order forms before and
after the introduction of the profiles. Data are shown as
percentages (* p< 0,001; ^p< 0,0006)
Table 3 Castelnovo nè Monti Puianello
Provisional diagnosis: Baseline Audit 15 22 *
Provisional diagnosis: 2nd Audit 58,2 42 ^
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iations were statistically significant (p< 0.001) (Table 2).
At the baseline audit the provisional diagnosis on
order forms was present in 15% of cases in the trial set-
ting and 22% in the control setting; the difference was
statistically significant (χ2 = 12.2, P< 0.001). After one
year, the provisional diagnosis on order forms was
present in about 52.8% in the trial setting and 42% in
the control setting; the difference was again statistically
significant (χ2 = 16.47 P< 0.0006) (Figure 3; Table 3).
Discussion
The profiles were defined by means of consensus in
order to facilitate joint actions. In this context clinical
pathologists are extremely useful members of multidis-
ciplinary teams that develop clinical profiles [11,12]. To
minimize the differences due to the complexity of the
behavioral objective defined in the study, two healthcare
districts that refer to the same laboratory were chosen as
the trial and the control setting. We did not plan to con-
duct a subsequent cross-over but only to extend the use
of profiles to the Puianello district.
The laboratory test ordering habits of GPs, expressed
by the number of tests per request form, measured the
compliance of the GPs with the indications in the pro-
files. Even in the district of Puianello the number of tests
per request form decreased, since at the time of the
study was introduced a regional law that required doc-
tors to write only 8 tests on each request form; however
the total number of tests increased and therefore the
number of request forms.
Although the pre-intervention ordering habits of GPs in
the trial setting were different from those in the control dis-
trict, they remained stable over time. Indeed, a significant
reduction in the number of tests ordered in the first audit
cycle, as compared to the baseline measurement of 2007
(about 5%), was observed only in the trial district, after ap-
plication of the profiles. In contrast, a constant annual in-
crease of about 6% was seen in the same district in the
preceding years. The number of request forms that indi-
cated a provisional diagnosis also increased significantly.
Conclusions
An appropriate use of pathology-specific laboratory pro-
files resulted in a decrease in total prescriptions and a
more accurate reporting of the requests, suggesting amore appropriate use of tests and a better allocation of
resources, with an improvement in the cost-benefit ratio.
The combined method used in this study improved
the prescriptive compliance in most of the GPs involved
over a fairly short period of time, while the GPs in the
control group generally maintained their previous test
ordering habits.
The involvement of the clinical pathologist was deemed
essential in the improvement planning stage as well as
during the audits and therefore is now always present at
meetings with GPs in the Castelnovo né Monti district.
The intention is to involve the GPs of the Puianello dis-
trict in the application of the pathology-specific laboratory
profiles as well.
Audits on this approach will be conducted periodic-
ally, new profiles will be added, and existing ones will be
updated. The results will continue to be discussed by the
interdisciplinary work team and will be made available
to all the GPs of the province of Reggio Emilia, on the
Reggio Emilia Health Authority intranet.
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